GHRP-6 Side Effects

Known side effects

The following side effects have been reported in research studies and user reports for GHRP-6:

• Intense appetite stimulation: The most notable and predictable side effect of GHRP-6. Hunger begins within 15 to 20 minutes of injection and can be quite severe, particularly at doses above 200 mcg. Users who do not need appetite enhancement often find this effect difficult to manage, especially with multiple daily injections. Timing injections directly before planned meals is the standard mitigation strategy
• Cortisol elevation: GHRP-6 produces transient cortisol increases with each injection, peaking around 30 minutes and resolving within 2 to 3 hours. High-frequency dosing (3 or more times daily) can produce cumulative cortisol exposure that impairs recovery or disrupts sleep. GHRP-6 typically produces more cortisol elevation than GHRP-2 at equivalent doses
• Prolactin elevation: Measurable prolactin increases follow GHRP-6 injection through GHS-R1a activation in pituitary lactotrophs. Chronic prolactin elevation across prolonged or high-dose protocols may contribute to gynecomastia risk in men or menstrual irregularities in women
• Water retention: GH elevation drives fluid retention through interactions with aldosterone and antidiuretic hormone. Mild to moderate bloating and peripheral edema are common during the first 2 to 4 weeks of use and typically diminish as the body adapts
• Injection site reactions: Localized redness, swelling, or mild pain at subcutaneous injection sites, particularly with repeated injections in the same location. Rotating sites across the abdomen reduces this effect
• Tingling or numbness: Transient peripheral tingling, most commonly in the hands, occurring in association with GH elevation and related fluid shifts. Typically mild and self-resolving within hours
• Potential for compulsive eating or overeating: Unlike GHRP-2's moderate hunger signal, GHRP-6's appetite stimulation can be difficult to distinguish from genuine hunger, potentially leading to excessive caloric intake if meal timing is not carefully planned around injections

Severity and frequency

Limited clinical data is available for GHRP-6. Side effect frequency and severity are based on available research and anecdotal reports. More data is needed for definitive safety profiles.

When to seek medical attention

Contact your healthcare provider immediately if you experience:

• Severe or persistent symptoms that do not improve
• Signs of an allergic reaction (rash, swelling, difficulty breathing)
• Severe abdominal pain
• Changes in vision or neurological symptoms
• Any symptom that concerns you

Risk factors

Side effect risk may be higher in certain populations. Discuss your complete medical history with your doctor, including:

• Pre-existing medical conditions
• Current medications (drug interactions)
• Pregnancy or plans to become pregnant
• History of allergic reactions to peptides or similar compounds
• Note: GHRP-6 is a research compound without established human safety data from FDA-approved clinical trials

Research references

• Comparison of growth hormone (GH)-releasing peptides: stimulation of GH release from perifused rat anterior pituitaries by GHRP-1, GHRP-2, GHRP-6, hexarelin, and MK-0677 — Endocrinology (1997) [PubMed]
• Growth hormone-releasing activity of a synthetic hexapeptide in normal volunteers and subjects with short stature — Journal of Clinical Endocrinology and Metabolism (1993) [PubMed]
• GHRP-6 increases food intake in healthy subjects and patients with anorexia nervosa — Clinical Endocrinology (1994) [PubMed]